These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23775012)

  • 1. Prognostic value of cyclin E expression in breast cancer: a meta-analysis.
    Gao S; Ma JJ; Lu C
    Tumour Biol; 2013 Dec; 34(6):3423-30. PubMed ID: 23775012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.
    Wang L; Shao ZM
    Cancer Invest; 2006 Oct; 24(6):581-7. PubMed ID: 16982462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient.
    Husdal A; Bukholm G; Bukholm IR
    Cell Oncol; 2006; 28(3):107-16. PubMed ID: 16823179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of VEGF-C immunohistochemical expression in breast cancer: a meta-analysis.
    Gao S; Ma JJ; Lu C
    Tumour Biol; 2014 Feb; 35(2):1523-9. PubMed ID: 24078449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment.
    Chappuis PO; Donato E; Goffin JR; Wong N; Bégin LR; Kapusta LR; Brunet JS; Porter P; Foulkes WD
    Ann Oncol; 2005 May; 16(5):735-42. PubMed ID: 15802279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
    Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
    Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
    Luhtala S; Staff S; Tanner M; Isola J
    Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.
    Porter PL; Barlow WE; Yeh IT; Lin MG; Yuan XP; Donato E; Sledge GW; Shapiro CL; Ingle JN; Haskell CM; Albain KS; Roberts JM; Livingston RB; Hayes DF
    J Natl Cancer Inst; 2006 Dec; 98(23):1723-31. PubMed ID: 17148774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis.
    Ji YN; Wang Q; Li Y; Wang Z
    Tumour Biol; 2014 Mar; 35(3):2787-93. PubMed ID: 24234334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
    Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
    Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel interaction between HER2/neu and cyclin E in breast cancer.
    Mittendorf EA; Liu Y; Tucker SL; McKenzie T; Qiao N; Akli S; Biernacka A; Liu Y; Meijer L; Keyomarsi K; Hunt KK
    Oncogene; 2010 Jul; 29(27):3896-907. PubMed ID: 20453888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.
    Peng L; Zhou Y; Wang Y; Mou H; Zhao Q
    PLoS One; 2013; 8(3):e58891. PubMed ID: 23527044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.
    Kim HK; Park IA; Heo DS; Noh DY; Choe KJ; Bang YJ; Kim NK
    Eur J Surg Oncol; 2001 Aug; 27(5):464-71. PubMed ID: 11504517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
    Sieuwerts AM; Look MP; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; de Weerd V; Portengen H; Klijn JG; Foekens JA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3319-28. PubMed ID: 16740753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis.
    Zhan P; Ji YN; Yu LK
    Transl Androl Urol; 2013 Jun; 2(2):99-105. PubMed ID: 26816732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
    Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
    Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.
    Waltersson MA; Askmalm MS; Nordenskjöld B; Fornander T; Skoog L; Stål O
    Int J Oncol; 2009 Feb; 34(2):441-8. PubMed ID: 19148479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of cyclin E expression in operable breast cancer.
    Potemski P; Kusińska R; Pasz-Walczak G; Piekarski JH; Watała C; Płuciennik E; Bednarek AK; Kordek R
    Med Sci Monit; 2009 Feb; 15(2):MT34-40. PubMed ID: 19179977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model.
    Liang Y; Gao H; Lin SY; Goss JA; Brunicardi FC; Li K
    PLoS One; 2010 Sep; 5(9):e12860. PubMed ID: 20877462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.